Intelligence · Clinical Development
Pipeline search results
Programs matching “asthma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 226 pipeline programs matching "asthma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
CLI-05993AA5-06
Chiesi Farmaceutici S.p.A
Uncontrolled Asthma
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Asthma
1 trial -
D3250C00101
AstraZeneca AB
Eosinophilic Asthma
1 trial -
D3252C00002
AstraZeneca AB
Severe CRSwNP patients with asthma.
1 trial -
D5180C00016
AstraZeneca AB
Severe Uncontrolled Asthma Asthma (an illness that causes breathing difficulty) that is not fully controlled, so that asthma attacks are still occurring despite the use of other available treatments
1 trial -
D5982C00006
AstraZeneca AB
Inadequately Controlled Asthma
1 trial -
D5982C00007
AstraZeneca AB
Severe and inadequately controlled asthma
1 trial -
D5982C00008
AstraZeneca AB
Severe and inadequately controlled asthma
1 trial -
Dupilumab Prefilled Syringe
Regeneron UK Limited
Asthma Control
1 trial -
Dupilumab SAR231893
Regeneron UK Limited
Asthma
1 trial -
Dupilumab SAR231893 (REGN668)
Regeneron UK Limited
Asthma
2 trials -
E004 (Epinephrine Inhalation Aerosol) HFA-MDI
Amphastar France Pharmaceuticals
Asthma
1 trial -
EFC14771
Sanofi-aventis Healthcare Pty Ltd
Respiratory tract diseases - Wheezing, Asthma
1 trial -
Epinephrine HFA-MDI (E004)
Amphastar France Pharmaceuticals
Asthma
1 trial -
Experimental: Tezepelumab
AstraZeneca
Asthma
1 trial -
FF/UMEC/VI
GlaxoSmithKline
Asthma
1 trial -
FF/UMEC/VI
Grace Therapeutics
Asthma
1 trial -
FS MDPI
Teva Pharma GmbH
Asthma
2 trials -
Fluticasone Propionate
Teva Pharma GmbH
Asthma
1 trial -
Fluticasone Propionate and Salmeterol Inhalation Powder
Teva Pharma GmbH
Asthma
1 trial -
Fluticasone propionate pressurized metered dose inhaler
Teva Pharma GmbH
Asthma
1 trial -
Fluticasone/ Formoterol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Asthma
1 trial -
Fp MDPI
Teva Pharma GmbH
Persistent Asthma
1 trial -
Fp/ABS
Teva Pharma GmbH
Asthma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.